DISCOUNT OPTIONSSCHEIN - ABBOTT LABORATORIES Share Price

Certificat

DE000ME9G2N5

Real-time Bid/Ask 07:45:11 31/05/2024 BST
0.033 EUR / 0.047 EUR +8.11% Intraday chart for DISCOUNT OPTIONSSCHEIN - ABBOTT LABORATORIES
Current month-19.57%
1 month-19.57%
Date Price Change
30/05/24 0.037 0.00%
29/05/24 0.037 +8.82%
28/05/24 0.034 0.00%
27/05/24 0.034 -12.82%
24/05/24 0.039 -2.50%

Delayed Quote Börse Stuttgart

Last update May 30, 2024 at 05:59 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN ME9G2N
ISINDE000ME9G2N5
Date issued 01/03/2024
Strike 150 $
Maturity 20/12/2024 (204 Days)
Parity 10 : 1
Emission price 0.07
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.118
Lowest since issue 0.034
Spread 0.013
Spread %27.66%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
101.7 USD
Average target price
125.4 USD
Spread / Average Target
+23.23%
Consensus